Latest Data


« New Entry Fda Approves Ge Healthcare’s Adreview (iobenguane I 123 Injection) Diagnostic Agent For Detecting Neuroendocrine Tumors In Children, Adults | Main | Updated Smokeless Tobacco Can Also Increase Cancer Risk »

Subject New European Survey Highlights Need For Improvement In Chronic Myeloid Leukaemia Monitoring (cml)

By admin2 | November 17, 2008

MedicalData from a new survey of 550 physicians and specialists across Europe indicate that 47% of physicians are not carrying out regular molecular monitoring for patients with Chronic Myeloid Leukaemia (CML).1 Results from the UK show that a quarter of physicians surveyed do not follow molecular monitoring recommendations; this may impact clinical decision making in CML.
(Link)

This entry was important to me: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • StumbleUpon
  • Digg
  • del.icio.us
  • Reddit
  • Furl
  • Junipo

Topics: Cancer |

Comments